You are here » Home » Companies » Company Overview » Shilpa Medicare Ltd

Shilpa Medicare Ltd.

BSE: 530549 Sector: Health care
NSE: SHILPAMED ISIN Code: INE790G01031
BSE 15:46 | 16 Jan 594.70 -12.80
(-2.11%)
OPEN

606.70

HIGH

611.45

LOW

588.00

NSE 15:51 | 16 Jan 594.05 -12.35
(-2.04%)
OPEN

609.40

HIGH

612.45

LOW

587.05

OPEN 606.70
PREVIOUS CLOSE 607.50
VOLUME 4515
52-Week high 748.95
52-Week low 537.10
P/E 32.32
Mkt Cap.(Rs cr) 4,847
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 606.70
CLOSE 607.50
VOLUME 4515
52-Week high 748.95
52-Week low 537.10
P/E 32.32
Mkt Cap.(Rs cr) 4,847
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Shilpa Medicare Ltd. (SHILPAMED) - Company History

Shilpa Medicare Ltd., formerly known as Shilpa Antibiotics was incorporated as a private limited company in Nov.'87 and has been promoted by Vishnukant C Bhutada and his associates.The company produces trimethoprim, an anti-biotic bulk drug. It also manufactures the product for other reputed companies like Eskayef, Bombay Drugs & Pharmas, Bombay Drug House, US Vitamins, Sandoz India, etc, for their export commitments. Circa 1992, the company installed production facilities to manufacture sodium methoxide. SAL is the recipient of the World Health Organisation - Good Manufacturing Practices (GMP) certificate. It exports its products to hard-currency areas. The company manufactures 1-methyl, amino-1-methyl, thio-2-nitro ethane, a drug intermediate used in the manufacture of ranitidine, an anti-ulcer drug. The company proposes to embark upon an expansion project which involves the addition of one more bulk drug to its existing product range -- norfloxacin -- and expand the production capacity of the existing products of the company -- sodium methoxide and trimethoprim.